This inhibition is mediated through activation of the phosphoinositide 3-kinase (PI3K) and Akt signaling pathways, collectively hindering apoptosis in tumor cells and granting survival advantage under adverse conditions (36). The gene discussed is AKT1; the disease is neoplasm.